Evidence map›Paper›PMID 40866265›Full record

ArticleInternal medicine (Tokyo, Japan)2026

Post-acute Corticospinal and Spinal Tractopathy after Coronavirus Disease 2019: A Novel Post-infectious Neurological Syndrome?

Nobuhiko Ohashi, Naoya Miyahara, Ko-Ichi Tazawa, Ken Takasone, Yumi Hoshino, Yasufumi Kondo, Akira Matsushima, Kanji Yamamoto, Yoshiki Sekijima

Abstract readCase Reports
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Nobuhiko OhashiDepartment of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Japan.
Naoya MiyaharaNorth Alps Medical Center Azumi Hospital, Japan.
Ko-Ichi TazawaDepartment of Neurology, Nagano Red Cross Hospital, Japan.
Ken TakasoneDepartment of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Japan.
Yumi HoshinoDepartment of Neurology, Nagano Prefectural Rehabilitation Center, Japan.
Yasufumi KondoDepartment of Neurology, Nagano Municipal Hospital, Japan.
Akira MatsushimaDepartment of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Japan.
Kanji YamamotoDepartment of Neurology, Nagano Municipal Hospital, Japan.
Yoshiki SekijimaDepartment of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We herein report two cases of tractopathy affecting the bilateral corticospinal tracts (CSTs) and the spinal cord following coronavirus disease 2019. Both patients developed progressive sensorimotor deficits with spasticity, a truncal sensory level with severely impaired deep sensation, and bowel/bladder dysfunction one to three months post-infection. Magnetic resonance imaging revealed bilateral CST and lateral column lesions. Somatosensory evoked potentials confirmed posterior column dysfunction. Initial treatment with intravenous methylprednisolone and immunoglobulin was ineffective; however, multiple courses of immunotherapy and prolonged corticosteroids led to marked improvement. These cases suggest a tract-specific, delayed, immune-mediated process triggered by severe acute respiratory syndrome coronavirus 2, underscoring the need for extended immunotherapy for optimal recovery.

Indexed as

COVID-19Pyramidal TractsSpinal Cord DiseasesAgedFemaleHumansMagnetic Resonance ImagingMaleMethylprednisoloneMiddle AgedSARS-CoV-2Methylprednisolonecorticospinal tractCOVID-19immunotherapytractopathy

Identifiers

PMID40866265
PMCPMC13106820

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.